Tetsuro Sasada Selected Research

C-Reactive Protein

10/2023	Survival and biomarkers for cachexia in non-small cell lung cancer receiving immune checkpoint inhibitors.
1/2020	C-reactive protein at 1 month after treatment of nivolumab as a predictive marker of efficacy in advanced renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tetsuro Sasada Research Topics

Disease

76	Neoplasms (Cancer) 12/2024 - 09/2003
20	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 09/2007
11	Pancreatic Neoplasms (Pancreatic Cancer) 12/2024 - 07/2007
11	Prostatic Neoplasms (Prostate Cancer) 05/2020 - 12/2010
5	Melanoma (Melanoma, Malignant) 07/2017 - 05/2011
5	Leukemia 09/2013 - 02/2002
4	Renal Cell Carcinoma (Grawitz Tumor) 12/2024 - 01/2020
4	Adenocarcinoma 12/2022 - 04/2004
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 09/2009
3	Colorectal Neoplasms (Colorectal Cancer) 10/2019 - 12/2014
3	Lung Neoplasms (Lung Cancer) 01/2019 - 06/2004
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 05/2017 - 03/2012
2	Carcinoma (Carcinomatosis) 01/2023 - 12/2017
2	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 10/2013
2	Urinary Bladder Neoplasms (Bladder Cancer) 09/2018 - 01/2016
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2017 - 04/2012
2	Hepatocellular Carcinoma (Hepatoma) 09/2017 - 01/2015
2	Hypersensitivity (Allergy) 07/2017 - 01/2016
2	Neoplasm Metastasis (Metastasis) 07/2014 - 02/2008
2	Experimental Melanoma 04/2014 - 05/2011
2	Human Influenza (Influenza) 10/2012 - 06/2011
2	Stomach Neoplasms (Stomach Cancer) 06/2004 - 04/2004
1	Malignant Mesothelioma 01/2024
1	Cachexia 10/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2023
1	Cytokine Release Syndrome 01/2023
1	Esophageal Neoplasms (Esophageal Cancer) 10/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2019
1	Fibrosis (Cirrhosis) 07/2019
1	Hypersplenism (Anemia, Splenic) 07/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Non-Muscle Invasive Bladder Neoplasms 09/2018

Drug/Important Bio-Agent (IBA)

50	Peptides (Polypeptides)IBA 12/2024 - 04/2004
33	AntigensIBA 01/2024 - 10/2004
16	Cancer VaccinesIBA 12/2024 - 04/2007
16	Protein Subunit VaccinesIBA 01/2023 - 04/2007
15	VaccinesIBA 01/2023 - 04/2007
14	Immune Checkpoint InhibitorsIBA 04/2024 - 05/2013
13	Biomarkers (Surrogate Marker)IBA 12/2023 - 12/2010
12	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2004
9	EpitopesIBA 01/2019 - 04/2004
8	CytokinesIBA 12/2023 - 09/2013
7	Immunoglobulin G (IgG)IBA 10/2015 - 07/2007
6	HLA Antigens (Human Leukocyte Antigens)IBA 12/2024 - 04/2007
6	Messenger RNA (mRNA)IBA 10/2021 - 04/2004
5	Interleukin-6 (Interleukin 6)IBA 04/2024 - 05/2008
4	Docetaxel (Taxotere)FDA Link 05/2020 - 08/2009
4	AntibodiesIBA 01/2020 - 07/2007
4	PlatinumIBA 12/2017 - 09/2007
3	Therapeutic UsesIBA 01/2022 - 06/2004
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2019 - 06/2011
3	LigandsIBA 11/2017 - 08/2014
3	ErbB Receptors (EGF Receptor)IBA 01/2016 - 01/2013
3	Cisplatin (Platino)FDA LinkGeneric 08/2009 - 06/2004
2	Chimeric Antigen ReceptorsIBA 01/2024 - 01/2022
2	C-Reactive ProteinIBA 10/2023 - 01/2020
2	Immune Checkpoint ProteinsIBA 09/2018 - 01/2016
2	HLA-A Antigens (HLA-A)IBA 07/2018 - 06/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2017 - 02/2016
2	HaptoglobinsIBA 12/2015 - 01/2013
2	Tyrosine Kinase InhibitorsIBA 01/2014 - 01/2013
2	Gefitinib (Iressa)FDA Link 01/2014 - 01/2013
2	HLA-A*02:01 antigenIBA 11/2013 - 06/2011
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2013 - 09/2009
2	TubulinIBA 08/2009 - 06/2009
2	Fluorouracil (Carac)FDA LinkGeneric 02/2008 - 06/2004
2	Monomeric GTP-Binding ProteinsIBA 04/2007 - 10/2004
2	HLA-A*33 antigenIBA 04/2007 - 04/2004
1	NucleotidesIBA 12/2024
1	Monoclonal AntibodiesIBA 01/2024
1	GhrelinIBA 10/2023
1	OsteopontinIBA 10/2023
1	pullulanIBA 01/2023
1	polyethylene glycol polyethyleneimine nanogelIBA 01/2023
1	ChemokinesIBA 01/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023
1	Cytokine Receptor gp130IBA 01/2023
1	CarbonIBA 12/2022
1	Surface Antigens (Surface Antigen)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 10/2021
1	Gemcitabine FDA Link 10/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2020
1	Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA 01/2020
1	NivolumabIBA 01/2020
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2019
1	N 30IBA 01/2019
1	MesothelinIBA 07/2018

Therapy/Procedure

28	Immunotherapy 12/2024 - 04/2004
19	Drug Therapy (Chemotherapy) 12/2022 - 06/2004
15	Therapeutics 12/2023 - 08/2009
10	Castration 05/2020 - 12/2010
7	Aftercare (After-Treatment) 10/2021 - 06/2012
2	Radiotherapy 12/2022 - 01/2020
2	Splenectomy 07/2019 - 05/2008
2	Immunomodulation 01/2016 - 09/2003
2	Hematopoietic Stem Cell Transplantation 09/2013 - 09/2009